Prediction of adult overweight during the pediatric years

Q He1, J Karlberg

  • 1Department of Pediatrics, The University of Hong Kong, Hong Kong SAR, PR China.

Pediatric Research
|December 10, 1999
PubMed

Insights

Identifying at-risk children early is crucial for preventing adult obesity. This study developed probability charts using Body Mass Index (BMI) to predict childhood obesity risk up to 18 years of age.

Area of Science:

  • Pediatric Endocrinology
  • Public Health
  • Growth and Development

Background:

  • Adult obesity is linked to higher mortality rates from various diseases.
  • Childhood overweight and obesity often persist into adulthood, necessitating early identification of at-risk individuals.

Purpose of the Study:

  • To develop a novel instrument for identifying children at high risk of adult obesity.
  • To enable earlier clinical intervention for pediatric obesity prevention.

Main Methods:

  • Utilized data from a longitudinal growth study of 3650 Swedish children from birth to 18 years.
  • Employed Body Mass Index (BMI) measurements during childhood to estimate the risk of adult obesity.
  • Constructed probability charts correlating pediatric BMI with the likelihood of being overweight at 18 years of age.

Main Results:

  • Established probability charts to predict the risk of becoming overweight (>25 kg/m2) by age 18.
  • Demonstrated example risks: a 4-year-old girl with BMI 16 kg/m2 has a 20% risk; a 4-year-old boy with BMI 19 kg/m2 has a 60% risk of adult overweight.
  • These charts represent the first probability risk assessment tool for adult overweight developed from pediatric data.

Conclusions:

  • The developed probability charts offer an easy and novel method for identifying children at high risk for adult obesity.
  • Early identification facilitates timely clinical interventions, potentially mitigating long-term health consequences of obesity.

Related Concept Videos

Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.